Thrombolysis for ischaemic stroke: Impact of the extension of the time-window in daily practice

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 2, 2012, Pages 227-228

  Mihout, Marie ^a   Cordonnier, Charlotte ^b,c   Girard Buttaz, Isabelle ^a   Leys, Didier ^b,c  

^a Hospital of Valenciennes   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; AGED; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FRANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; RETROSPECTIVE STUDY; SCORING SYSTEM; SMOKING;

EID: 84855580754     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.226027     Document Type: Letter

References (5)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
3. Rudd AG, Hoffman A, Grant R, et al. Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry 2011;82:14-19.
4. Bodenant M, Leys D, Debette S, et al. Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours. Cerebrovasc Dis 2010;30:148-56.
5. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703.